New flu pill shows promise for teens in Late-Stage trial
NCT ID NCT07229820
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 3 trial tests whether the experimental drug ZSP1273 can shorten flu symptoms in teenagers aged 12-17 with uncomplicated influenza A. About 157 participants in China will receive either the drug or a placebo. The main goal is to see how quickly symptoms like cough, fever, and body aches improve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ZSP1273
- What this could lead to
- If it works, this could provide a new treatment option to reduce flu symptoms faster in teenagers.
- What could go wrong
- This is a mid-stage trial with only 157 participants, so results may not confirm effectiveness or safety for wider use. The drug is still experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE UNCOMPLICATED INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ruijin Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New rapid test could spot COVID and flu in minutes
- New rapid test could spot flu and RSV in minutes at your local clinic
- New swab test aims to spot COVID, flu, and RSV in minutes
- New device aims to detect flu, RSV, and COVID-19 in one quick test
- Rapid COVID and flu tests put to the test in real clinics
- New At-Home test could detect flu and COVID in minutes